Hot Pursuit     06-Feb-25
Biocon Ltd soars 1.76%, rises for third straight session
Biocon Ltd is quoting at Rs 397.1, up 1.76% on the day as on 12:49 IST on the NSE. The stock is up 36.81% in last one year as compared to a 7.61% gain in NIFTY and a 18.78% gain in the Nifty Pharma index.

Biocon Ltd rose for a third straight session today. The stock is quoting at Rs 397.1, up 1.76% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.41% on the day, quoting at 23600.05. The Sensex is at 77920.62, down 0.45%. Biocon Ltd has added around 3.86% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 5.07% in last one month and is currently quoting at 21868.5, up 0.83% on the day. The volume in the stock stood at 32.7 lakh shares today, compared to the daily average of 64.56 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 396.75, up 1.48% on the day. Biocon Ltd is up 36.81% in last one year as compared to a 7.61% gain in NIFTY and a 18.78% gain in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 24.

Previous News
  Biocon Ltd spurts 1.95%, up for third straight session
 ( Hot Pursuit - 12-Nov-25   13:05 )
  Biocon reports consolidated net profit of Rs 84.50 crore in the September 2025 quarter
 ( Results - Announcements 12-Nov-25   07:46 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 06-Nov-25   13:05 )
  Biocon's biologics arm gets Health Canada approval for monoclonal antibody drug Yesintek
 ( Hot Pursuit - 23-Oct-25   12:58 )
  Biocon Biologics expands its strategic collaboration with Civica
 ( Corporate News - 16-Oct-25   16:28 )
  Biocon inaugurates first US manufacturing facility in New Jersey
 ( Hot Pursuit - 13-Oct-25   08:16 )
  Biocon's subsidiary get US FDA approval for diarrhea medication Rifaximin
 ( Hot Pursuit - 07-Oct-25   09:58 )
  Biocon schedules board meeting
 ( Corporate News - 07-Oct-25   09:43 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 01-Oct-25   13:05 )
  Biocon Biologics inks settlement and license agreement with Amgen Inc.
 ( Corporate News - 01-Oct-25   10:33 )
  Biocon gains on U.S. entry for denosumab biosimilars
 ( Hot Pursuit - 01-Oct-25   10:13 )
Other Stories
  TMPV Q2 PAT skyrockets 2,110% YoY to Rs 76,170 cr on commercial vehicle demerger
  14-Nov-25   17:37
  Marico Q2 PAT slides 17% QoQ to Rs 420 cr
  14-Nov-25   17:11
  LG Electronics India drops after Q2 PAT slumps 27% YoY to Rs 389 cr
  14-Nov-25   15:39
  Apollo Tyres slides after Q2 PAT slumps 13% YoY to Rs 258 cr
  14-Nov-25   15:12
  B. L. Kashyap and Sons tumbles after reporting Rs 9 cr net loss in Q2
  14-Nov-25   15:06
  Prakash Industries Ltd leads losers in 'A' group
  14-Nov-25   15:00
  GMDC slumps as Q2 revenue slides 11% YoY
  14-Nov-25   15:00
  Wealth First Portfolio Managers Ltd leads losers in 'B' group
  14-Nov-25   14:45
  Volumes spurt at Sagility Ltd counter
  14-Nov-25   14:30
  Paras Defence surges after Q2 PAT jumps 49% YoY to Rs 21 cr
  14-Nov-25   14:26
Back Top